1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow HER2+ Advanced Breast Cancer: new trials by email Literature Review of HER2+ Advanced Breast Cancer trials Research Report on HER2+ Advanced Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors Chimeric receptor T-cells + Trastuzumab, Fludarabine and Cyclophosphosphamide - HER2+ Advanced Breast Cancer, Other Solid Tumors | Phase 1 / Phase 2 | Not yet recruiting | National University Hospital, Singapore | 36 | 2026-11-01 | 2025-09-23 |
| Culmerciclib in HR+/HER2+ Advanced Breast Cancer Culmerciclib - Breast Cancer, Metastastic Breast Cancer | Phase 2 | Recruiting | Sun Yat-sen University | 35 | 2026-08-01 | 2026-07-29 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Trastuzumab (1) · fludarabine (1)
National University Hospital, Singapore (1) · Sun Yat-sen University (1)
China (1)
Soo Chin Lee (1)